• Home
• Defective Drug Index
• About A Drug Recall
• Contact A Defective Drug Lawyer

We Can Help.

Accolate

Accolate is a nonsteroidal tablet intended for the prevention and continuous treatment of asthma in children and adults. FDA approved in September 1996, Accolate is manufactured by Zeneca Pharmaceuticals. In approximately 10 months on the market, Accolate was prescribed to around 250,000 U.S. patients.

On July 22, 1997, the manufacturer of Accolate sent a letter to healthcare professionals that the company was making changes to the enclosed package insert for the asthma drug. Included in the revisions were warnings that the drug had been associated to rare occurrences of eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy sometimes presenting as Churg Strauss Syndrome. The Precautions and Adverse Reactions sections of the revised package insert for Accolate included the changes.

Individuals that have experienced adverse effects from taking prescription asthma medication Accolate should contact us to learn your legal rights and options.

More Accolate Resources

MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.

Accolate (Zafirkulast) - contains information about a nonsteroidal asthma preventative and treatment from AstraZeneca.

• Reglan
• Raptiva
• Yaz Birth Control
• Nuvaring
• Duragesic Patch
• Heparin